Research Article

MARKET RISK PREMIUMS IN BIST 100 IN THE COVID ERA

Volume: 14 Number: 1 December 31, 2021
EN

MARKET RISK PREMIUMS IN BIST 100 IN THE COVID ERA

Abstract

Purpose- Capital Asset Pricing Model (CAPM) is the most widely used and popular method in analysis of investment projects, stock valuation, firm valuation, mergers and acquisitions, initial public offerings and secondary public offerings. The determination of market risk premium is one of the most important inputs in the application of this model. The determination of market risk premium for the Turkish market has not deeply studied in the literature so far. This study intends to calculate the market risk premium for the Turkish Stock Market with a special emphasis on the Covid-19 era. Methodology- The monthly data from the Reuters Database are collected for the BIST100 and 17 different sectoral indexes for the years of 2019 and 2020. Moreover, the monthly average short term interest rates on the Turkish Treasury Bonds are obtained from the database of Central Bank of Turkey for the years of 2019 and 2020. Based upon the historical observations, the market risk premium is defined as the difference in between the market index returns (BIST100 and 17 sectoral indexes) and the average short term interest rates on monthly basis. Findings- The market risk premiums measured on BIST100 index are about 10% in 2019 and 20% in 2020. The market risk premium is doubled in the Covid era. The volatilities of BIST100 index are 7.86% in 2019 and 8.15% in 2020. The volatility of market risk premiums are also significantly increased in the Covid era. Conclusion- Covid era has significantly increased the market risk premiums and volatilities of the Turkish market. The results of this study may be used as a reference study for local and international financial institutions, valuation industry and trade firms and academics for an approximation of market risk premium in the Covid era.

Keywords

References

  1. Adjei, F. (2020). Effect of Economic Policy Uncertainty on Market Risk and Market Risk Premium. Journal of Finance and Economics, 8(2), 57- 60.
  2. Ahn, S., & Shrestha, K. (2009). Estimation of market risk premium for Japan. Journal Name: Enterprise Risk Management, 1(1), 33-43.
  3. Arismendi-Zambrano, J., & Azevedo, R. (2020). Implicit Entropic Market Risk-Premium from Interest Rate Derivatives. Available at SSRN: https://ssrn.com/abstract=3654217.
  4. Baghdadabad, M. R. T. (2017). Retraction Note to: Traditional beta, average drawdown beta and market risk premium. Journal of Asset Management, 18(2), 155-155.
  5. Bali, T. G., Cakici, N., & Chabi-Yo, F. (2015). A new approach to measuring riskiness in the equity market: Implications for the risk premium. Journal of Banking & Finance, 57, 101-117.
  6. Bhar, R., & Chiarella, C. (2007). A Model for the Ex-Ante UK Stock Market Risk Premium. Journal of Applied Quantitative Methods, 5(4), 599- 606.
  7. Blasi, P., Cohen, A., & Simon, A. (2015). The determinants of historical property market risk premium in the London office market (No. eres2015_207). European Real Estate Society (ERES).
  8. Bonga-Bonga, L. (2010). The assessment of market risk premium in South Africa. Journal of Applied Business Research (JABR), 26(6), 85-94.

Details

Primary Language

English

Subjects

Finance, Business Administration

Journal Section

Research Article

Publication Date

December 31, 2021

Submission Date

November 16, 2021

Acceptance Date

December 7, 2021

Published in Issue

Year 2021 Volume: 14 Number: 1

APA
Teker, S., Teker, D., & Demırel, E. (2021). MARKET RISK PREMIUMS IN BIST 100 IN THE COVID ERA. PressAcademia Procedia, 14(1), 110-112. https://doi.org/10.17261/Pressacademia.2021.1498
AMA
1.Teker S, Teker D, Demırel E. MARKET RISK PREMIUMS IN BIST 100 IN THE COVID ERA. PAP. 2021;14(1):110-112. doi:10.17261/Pressacademia.2021.1498
Chicago
Teker, Suat, Dilek Teker, and Esin Demırel. 2021. “MARKET RISK PREMIUMS IN BIST 100 IN THE COVID ERA”. PressAcademia Procedia 14 (1): 110-12. https://doi.org/10.17261/Pressacademia.2021.1498.
EndNote
Teker S, Teker D, Demırel E (December 1, 2021) MARKET RISK PREMIUMS IN BIST 100 IN THE COVID ERA. PressAcademia Procedia 14 1 110–112.
IEEE
[1]S. Teker, D. Teker, and E. Demırel, “MARKET RISK PREMIUMS IN BIST 100 IN THE COVID ERA”, PAP, vol. 14, no. 1, pp. 110–112, Dec. 2021, doi: 10.17261/Pressacademia.2021.1498.
ISNAD
Teker, Suat - Teker, Dilek - Demırel, Esin. “MARKET RISK PREMIUMS IN BIST 100 IN THE COVID ERA”. PressAcademia Procedia 14/1 (December 1, 2021): 110-112. https://doi.org/10.17261/Pressacademia.2021.1498.
JAMA
1.Teker S, Teker D, Demırel E. MARKET RISK PREMIUMS IN BIST 100 IN THE COVID ERA. PAP. 2021;14:110–112.
MLA
Teker, Suat, et al. “MARKET RISK PREMIUMS IN BIST 100 IN THE COVID ERA”. PressAcademia Procedia, vol. 14, no. 1, Dec. 2021, pp. 110-2, doi:10.17261/Pressacademia.2021.1498.
Vancouver
1.Suat Teker, Dilek Teker, Esin Demırel. MARKET RISK PREMIUMS IN BIST 100 IN THE COVID ERA. PAP. 2021 Dec. 1;14(1):110-2. doi:10.17261/Pressacademia.2021.1498

PressAcademia Procedia (PAP) publishes proceedings of conferences, seminars and symposiums. PressAcademia Procedia aims to provide a source for academic researchers, practitioners and policy makers in the area of social and behavioral sciences, and engineering.

PressAcademia Procedia invites academic conferences for publishing their proceedings with a review of editorial board. Since PressAcademia Procedia is an double blind peer-reviewed open-access book, the manuscripts presented in the conferences can easily be reached by numerous researchers. Hence, PressAcademia Procedia increases the value of your conference for your participants. 

PressAcademia Procedia provides an ISBN for each Conference Proceeding Book and a DOI number for each manuscript published in this book.

PressAcademia Procedia is currently indexed by DRJI, J-Gate, International Scientific Indexing, ISRA, Root Indexing, SOBIAD, Scope, EuroPub, Journal Factor Indexing and InfoBase Indexing. 

Please contact to contact@pressacademia.org for your conference proceedings.